Rabeprazole Is Effective in Treating Laryngopharyngeal Reflux in a Randomized Placebo-Controlled Trial  Paul K.Y. Lam, Manwa L. Ng, Ting K. Cheung, Birgitta Y.H. Wong, Victoria P.Y. Tan, Daniel Y.T. Fong, William I. Wei, Benjamin C.Y. Wong  Clinical Gastroenterology and Hepatology  Volume 8, Issue 9, Pages 770-776 (September 2010) DOI: 10.1016/j.cgh.2010.03.009 Copyright © 2010 AGA Institute Terms and Conditions

Figure 1 Average RSI obtained at week 0, week 6, week 12, and week 18 from patients in the rabeprazole group (solid line) and the placebo group (dotted line). Error bars indicate the standard error of the mean RSI values. Clinical Gastroenterology and Hepatology 2010 8, 770-776DOI: (10.1016/j.cgh.2010.03.009) Copyright © 2010 AGA Institute Terms and Conditions

Figure 2 Average RFS obtained at week 0, week 6, week 12, and week 18 from patients in the rabeprazole group (solid line) and the placebo group (dotted line). Error bars indicate the standard error of the mean RFS values. Clinical Gastroenterology and Hepatology 2010 8, 770-776DOI: (10.1016/j.cgh.2010.03.009) Copyright © 2010 AGA Institute Terms and Conditions